Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Recursion Pharmaceuticals Inc’s current trading price is -63.95% away from its 52-week high, while its distance from the 52-week low is 17.57%. The stock’s price range over this period has fluctuated between $3.79 and $12.36. The company, operating within the financial sector, had a trading volume of approximately 10.6 million for the day, which was noticeably lower than the average daily share volume of 24.74 million over the last 3 months.
Recursion Pharmaceuticals Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $12.36 on 02/18/25 and the lowest value was $3.79 on 04/09/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Recursion Pharmaceuticals Inc (RXRX) has experienced a quarterly decline of -41.75% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.81B.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.60, with a change in price of -2.47. Similarly, Recursion Pharmaceuticals Inc recorded 22,303,828 in trading volume during the last 100 days, posting a change of -35.54%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for RXRX stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.08.
RXRX Stock Stochastic Average
Today, Recursion Pharmaceuticals Inc’s raw stochastic average for the past 50 days stands at 16.83%, indicating a decline from the raw stochastic average of the last 20 days, which was 18.50%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 15.13% and 15.40% respectively.
RXRX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant loss of -34.09% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -36.07%. Over the past 30 days, the price of RXRX has leaped by -1.20%. And in the last five days, it has fallen by -6.29%.
